Abstract-Just over 10 years ago, in June, 1997, in the Proceedings of the IEEE International Conference on Neural Networks, we published our first predictor of intrinsically disordered protein [1]. Since then, we have substantially improved our predictors, and more than 20 other laboratory groups have joined in efforts to improve the prediction of protein disorder. At the algorithmic level, prediction of protein intrinsic disorder is similar to the prediction of secondary structure, but, at the structural level, secondary structure and intrinsic disorder are entirely different. The secondary structure class called random coil or irregular differs from intrinsic disorder due to very different dynamic properties, with the secondary structure class being much less mobile than the region of disorder. At the biological level, unlike the prediction of secondary structure, the prediction of intrinsic disorder has been revolutionary. That is, for many years, experimentalists have provided evidence that some proteins lack fixed structure or are disordered (or unfolded) under physiological conditions. Experimentalists further are showing that, for some proteins, functions depended on the unstructured rather than structured state. However, these examples have been mostly ignored. To our knowledge, not one disordered protein or disorder-associated function is discussed in any biochemistry textbook, even though such examples began to be discovered more than 50 years ago. Disorder prediction has been important for showing that the few experimentally characterized examples represent a very large cohort that is found all across all three domains of life. We now know that many significant biological functions depend directly on, or are importantly associated with, the unfolded or partially folded state. In this paper, we will briefly review some of the key discoveries that have occurred in the last decade, and, furthermore, will make a few highly speculative projections.
INTRODUCTION
Speculation that antibody binding depends on unfolded rather than structured protein goes back more than seventy years [2, 3] , when it was conjectured that high flexibility would enable one antibody molecule to bind to multiple antigens having different structures. The flexible antibody could randomly fluctuate among the different structures, with binding leading to the selection of the structure that fits with each different antigen [3] . The current body of evidence suggests that there are approximately two broad classes of antibodies, specific and non-specific. The sequence of a highly specific, high-affinity antibody folds into a specific structure that fits with its cognate antigen. On the other hand, the binding sites of low affinity, nonspecific antibodies are disordered in isolation but become differently folded when bound to different partners, thus confirming the early conjectures cited above (manuscript in preparation).
Experimental evidence supporting the view that some proteins remain unstructured, or incompletely structured, under physiological conditions began to be reported almost sixty years ago, with many additional papers as early as the next two decades [4] [5] [6] [7] [8] . Since the 1970s, an increased stream of disordered protein examples has been reported, and many of these are described in our database of intrinsically disordered proteins [9, 10] . In addition, this database contains a bibliography that shows explosive growth over the last few years, with more than 400 entries from 2006 alone.
One possibility is that the crowded conditions inside the cell cause intrinsically disordered proteins to fold into 3D structure. One test of this idea is to subject intrinsically disordered proteins to molecular crowding by adding high concentrations of agents such as glucose. Such in vitro molecular crowding experiments can induce folding of an acid-unfolded globular protein [11] , but fail to induce folding in several intrinsically disordered proteins [11, 12] .
Further recent studies along these lines suggest that some proteins remain unfolded even in the highly crowded environment inside the cell [13] [14] [15] . Another in-cell NMR report [16] involving some of the same authors was later retracted because protein leakage from the cells produced misleading data [17] . It is argued that the earlier experiments [13, 14] did not suffer from the same leakage problems, which appear to be specific for the protein used in the later studies [17] . Overall, these experiments provide some evidence that intrinsically disordered remain incompletely folded inside the cell, but clearly more experiments are needed to increase confidence in these studies.
A number of different terms have been used to describe these proteins, including natively denatured [18] , natively unfolded [19] , intrinsically unstructured [20] , and several variants of disordered [1, 21, 22] . By now, several reviews on these proteins have appeared [11, 12, [23] [24] [25] [26] [27] The development of a predictor of intrinsic protein disorder from amino acid sequence requires the prior assumption that disordered regions from different proteins have sequence features in common. Stated in another way, developing a predictor of protein disorder is in some sense testing the hypothesis that, just as the amino acid sequence codes for the 3D structure of a protein, the amino acid sequence codes also for the lack of 3D structure. If disorder is encoded in the amino acid sequence, then developing predictors of disorder provides a means to understand "the protein disorder code." In this regard, certain amino acids have been found to be highly "order-promoting" (namely cysteine, tryptophan, tyrosine, isoleucine, phenylalanine, valine, leucine, histidine, threonine, and asparagine) while others are highly "disorder-promoting" (namely aspartic acid, methionine, lysine, arginine, serine, glutamine, proline, and glutamic acid) [28] .
A significant development was the inclusion of disorder prediction among the exercises in the Critical Assessment of Structure Prediction (known as CASP), beginning with the 5 th CASP event and continuing in subsequent events [29, 30] . This has helped to stimulate the rapid development of at least 25 different predictors of protein disorder. A collection of links to many, if not most, of these is maintained at the Database of Disordered Protein website (www.disprot.org).
Several disordered protein predictors have been compared in recent publications [28, [31] [32] [33] [34] [35] [36] . As more disordered proteins have been identified, and as more sophisticated machine learning methods have been applied, the per residue prediction accuracy has risen from ~70% to ~85%. A likely-to-be significant impediment to further improvement is the misclassification of the residues in the training sets.
Application of the disorder predictors to various organisms in the three domains of life, namely, prokaryotes, archaea, and eukaryotes, reveals a large increase in disorder among the eukaryotes compared to the other two types of organisms [31, 37, 38] . One speculation to account for this observation is that the increased disorder reflects the increased need for signaling and coordination among the various organelles in the more complex eukaryotic domain [39] .
The recent explosion of papers on intrinsically disordered protein contains many new discoveries on these proteins by a large number of investigators. There is neither time nor space to adequately cover these important advances. We hope that other researchers in this field will not be offended by our focus on our own work for this paper, which has been written to accompany our lecture.
In the following, we will present four short stories that briefly review recent research on disordered proteins published by our group. These include the following: 1. a bioinformatics study of the relationship between disorder and function in the Swiss Protein Database [40] [41] [42] ; 2. the mechanisms by which one disordered region can bind to many partners and by which many different disordered sequences can bind to one site on one protein partner [43] thereby contributing to the complex protein-protein interaction networks that are observed in nature; 3. the observation that regions of mRNA that undergo alternative splicing code for disordered protein much more often than they code for structured protein [44] ; and 4. a novel method for drug discovery based on regions of disordered protein [45] . The novel drug discovery method suggests how the observations in the first three studies might be put to practical use.
II. INTRINSIC DISORDER AND PROTEIN FUNCTION
Our overall goal is to understand relationships between amino acid sequence and protein function so that, given a new sequence, possible functions could be suggested to interested experimentalists for laboratory testing. For proteins that form 3D structure, this is a well developed problem, but for intrinsically disordered proteins, work on this problem is just beginning. First we will very briefly review function prediction for structured proteins, and then we will compare and contrast the very limited amount of work in this area for intrinsically disordered proteins.
A. Function prediction for structured proteins
For structured proteins, sequence homology, if obvious enough, can provide leads regarding protein function [46] [47] [48] . Attempts to improve sequence matching for function prediction have been carried out [49] . If no suggestive homologue can be found, an alternative approach is to determine the 3D structure and then to search structure for functional clues, such as residues positioned in space like the same or functionally similar residues in known active sites [50] [51] [52] . Often evolution within a family of related proteins can be helpful by means of the evolutionary trace approach [53] . Recent advances have been made in the assessment of binding sites using both structural and sequence homology [54] .
B. Function prediction for disordered proteins
Our first efforts to associate disorder with function were carried out by means of manual literature searches. In the development of our protein disorder predictors, we wanted to use disorder characterized by methods other than missing coordinates in X-ray structures, especially to test whether disorder identified by different methods was different at the amino acid sequence level [55] . Therefore, we had accumulated manuscripts describing disordered proteins and regions of disorder characterized by other methods such as NMR, circular dichroism, small angle X-ray scattering, and so on. In addition, we found many examples in which the disorder indicated by missing coordinates in X-ray crystal structures had been confirmed by other methods. Given these proteins and their associated manuscripts, we then carried out literature searches for functions associated with these well studied disordered protein examples. Out of about 100 disordered proteins and regions, these manual searches identified 27 different functions, and at least one (and commonly more than one) of these functions was found to be associated with > 80% of the disordered proteins or regions. Of course when a given disordered region or protein has no associated function, it is unclear whether the given disordered protein has no function or whether the function of the given disordered protein has simply not yet been found [56, 57] .
For structured proteins, proteins can be grouped together if they display a common 3D fold as for example in the CATH [58] and SCOP [59] databases. Often these proteins with common folds have recognizable sequence similarity and so can be grouped into evolutionarily-related protein families. Sometimes, proteins have similar folds without recognizable sequence similarity [60] .
Just as for structured proteins, disordered proteins can be grouped into related sets by sequence matching. However, probably due to the absence of structural constraints, disordered proteins tend to accumulate mutations at higher rates than do structured proteins [61] so sequence matching might easily miss relationships between two disordered proteins. In addition, the conservation of the functionally important residues within a disordered region would tend to be obscured due to the high overall mutation rate. In the absence of structure, can sequence features (rather than sequence matching) be used to organize disordered proteins and regions into functional sets?
Over the years we have tried various clustering algorithms to identify functionally related groups of disordered proteins but so far with little or no success. We developed an alternative approach that partitioned a set of disordered proteins and regions into groups based on predictions of disorder. For this approach, a group of disordered proteins was randomly partitioned into two sets and disorder predictors were developed for each group. The two predictors were then applied to all the proteins, and the proteins were redistributed according to which predictor was more accurate. Predictor training was done again on the two redistributed sets, the competition was repeated, and the redistribution was repeated. These steps were carried out iteratively until assigned partitions converged. To test for reproducibility, the original group was randomly divided into two sets several times, and the process was repeated for each new initial partition. The final sets of proteins were very similar for the different initializations, with just a few of the proteins changing their associations in the different repetitions. [62] Next, the overall process was repeated for partitioning into three sets, into four sets, into five sets and into six sets. If the process were meaningful, one would expect improved agreement between disorder prediction and observation because the disordered proteins within a partitioned set would be more homogenous. Prediction clearly improved for partitions of two and three sets, but showed little or no improvement for increasing the number of partitions. These sets of disordered proteins were called flavors. For the division into three sets, the three distinct flavors were named V, C and S. [62] Finally, the functions of the various proteins in each set were identified. Some association was found between these flavors and the observed functions, e.g. S was associated with protein binding, V was associated with RNA binding, and C was associated with posttranslational modification sites [62] .
In our opinion, this approach should be revisited. There were several simplifications in this study that might have diminished the ability to discriminate different disorder flavors. In turn, the reduced ability to discriminate different flavors likely reduced the detection of flavor-function relationships.
A completely different approach is to search for the few, function-associated residues that remain conserved in the sea of changes among the surrounding disordered regions. Such conserved residues have been called Eukaryotic Linear Motifs (ELMs) and methods for their discovery from sequence, analogous to finding transcription factor binding sites, have been developed [63] [64] [65] .
The overall idea is to search for overabundance of particular residues in regions of sequence that lie outside of Pfam domains. The sets of sequences to be tested typically bind to one specific partner. Thus, evidently the conserved residues represent a binding motif within a linker between (Pfam) structured domains or in a disordered tail at the carboxy or amino terminus of a (Pfam) structured domain [65] .
We noticed several particular examples in which binding sites within disordered regions coincided with dips in our disorder prediction plots, especially PONDR VL-XT plots [66] , so we developed a predictor of binding sites within disordered regions based on disorder prediction [67] . We suggested that these segments contain molecular recognition features or MoRFs. Experimentalists have successfully used our predictors to discover sites of protein-protein interactions that were subsequently confirmed in laboratory experiments [68, 69] . Other studies have independently verified similarly predicted interactions [70] .
The ELM server predicts binding motifs based on overabundance of certain residues in regions known to bind to 1-4244-1509-8/07/$25.00 ©2007 IEEEa common partner. The MoRF predictor identifies sequence features commonly used for partner binding. Tompa and coworkers [71] showed that at least some MoRFs and ELMs have common characteristics. Developing a combination of the MoRF and ELM approaches might prove to be very useful.
The ELM approach excludes Pfam domains from analysis, which brings the focus most of the time to intrinsically disordered regions. However, a small fraction of the Pfam domains contains conserved regions of predicted disorder [72] and these disordered regions are implicated in biological functions [73] , thus giving a set of disorder-associated functional regions not located by ELM analysis. Further study of these Pfam-associated regions of disorder is necessary.
More recently we carried out an analysis of the functional annotation over the entire SwissProt database from a structured-versus-disordered point of view [40] [41] [42] . The overall idea was to find keywords associated with 20 or more proteins in SwissProt. For each keyword-associated set, a lengthmatching set of random proteins was drawn from SwissProt. Order-disorder predictions were carried out for the keywordassociated sets and for the random sets. If a function described by a given keyword were carried out by a long region of disordered protein, one would expect the keyword-associated set to have a greater amount of predicted disorder compared to the random set. The keyword-associated set would have less prediction of disorder compared to the random set if the keyword-associated function were carried out by structured protein. Given the two sets of predictions for the pairs of sets, it is possible to calculate the p-values, where a p-value > 0.95 suggests a disorder-associated function, a p-value < 0.05 suggests an order-associated function, and intermediate pvalues are ambiguous.
Out of 710 keywords each being assigned to at least 20 proteins, 310 had p-values < 0.05, suggesting order-associated functions, 238 had p-values > 0.95, suggesting disorderassociated functions, and the remainder, 170, gave intermediate p-values, yielding ambiguity in the likely function-structure associations [40] [41] [42] .
When the functional keywords were partitioned into eleven functional categories (Biological processes, cellular components, developmental stage, etc.) order-associated keywords were found for seven of the categories, but disorderassociated keywords were found for all eleven categories [40] . This observation supports a previous conjecture that the functional repertoire is larger for disordered proteins compared to that for structured proteins [21] .
Considering the biological processes category, the orderassociated keywords nearly all described processes carried out by (necessarily structured) enzymes (examples: amino acid biosynthesis, purine biosynthesis, lipid synthesis, etc.) or by (necessarily structured) integral membrane proteins (electron transport, sugar transport, ion transport). On the other hand, in this same category, the disorder-associated keywords described processes that typically involve control or regulation (differentiation, transcription, cell cycle, growth regulation, etc.). These observations slightly broaden an earlier conjecture that structured proteins are primarily associated with catalysis while disordered proteins are associated with signaling and regulation [21, 74] .
Finally, it is interesting to compare the individual keywords associated with disorder prediction and with those associated with the absence of disorder prediction (which indicate structure-associated functions). Ribonucleoprotein and ribosomal protein are two disorder-associated keywords with the highest Z-scores (values of 22.1 and 20.6, respectively). Interestingly, the Z-scores drop off to values less than 10 after just a few proteins. Oxidoreductase and transferase are the order-associated keywords with the highest Z-scores (values of -29.5 and -24.5, respectively). Furthermore, the drop-off to values less than 10 occurs more slowly for the order-associated keywords. One possible explanation is that the structured regions for most of the proteins comprise most of the amino acid sequence for the given protein whereas the disordered region might comprise a small part of the entire sequence.
Another interesting feature of these data is that the top 20 order-associated keywords all end in "ase," indicating that all are enzymes of one type or another. This suggests that, for the order-associated keywords, the overall approach works rather well. Although some laboratory genetic engineering experiments have yielded molten globules with enzymatic activity [75] , to our knowledge the currently known natural enzymes are structured proteins.
Further studies on the disorder-associated keywords involved ranking the proteins in each category by Z-score and then carrying out manual literature searches for evidence of association between disorder and function for the highestranking proteins. Indeed, for a significant fraction of the high Z-score proteins with functions predicted to be associated with disorder, an association between disorder and function was confirmed by these manual literature searches [41, 42] .
The tedious work of confirming the associations between disorder and function needs to be carried out for more of the protein groups in this study. It would then be interesting to study these groups of proteins by the methods described above or by new methods to find sequence-function relationships for disorder-associated functions. Such work would provide the basis for enabling researchers to infer function from sequence.
III. INTRINSIC DISORDER AND PROTEIN-PROTEIN INTERACTION NETWORKS
Protein-protein interaction networks involve a few proteins with many partners (called hub proteins or hubs) and many proteins with a few partners. The architecture and evolution of these networks comprise a very active area of research, e.g. [76] [77] [78] .
In a two-page News and Views article [79] commenting on a one-page article [80] on protein-protein interaction network architecture in the same issue of Nature, it was suggested that the ability of hub proteins to bind to many partners might depend on new principles. The question is, in essence, what feature of protein structure enables binding diversity?
We opened this paper with 70-year old conjectures that unfolded, dynamic protein ensembles could enable binding diversity. Since those initial conjectures, several additional papers, including several based on experimental data, suggested that lack of structure (e.g. disorder) could enable binding diversity [81] [82] [83] [84] .
To further test the roles of disorder in protein-protein interaction networks, first we collected a set of structurally characterized hub proteins [85] . We found several hub proteins to be entirely disordered from one end to the other, and yet to be capable of binding large numbers of partners. Other hubs contained both ordered and disordered regions. For these hubs, many, but not all, of the interactions mapped to the regions of disorder. Two highly structured hubs were found. For both of these structured hubs, the partners were found to be entirely disordered.
Overall, our initial study suggested two primary mechanisms by which disorder is utilized in protein-protein interaction networks. Several groups have tested these overall ideas further via bioinformatics studies on collections of hub proteins. Several of these studies support one of the two primary mechanisms, namely the common use of disordered regions by hub proteins to bind to multiple partners [86] [87] [88] [89] [90] . Additional bioinformatics studies refine the analysis further with the suggestion that disorder is very commonly used for regions that bind sequentially to multiple partners (so called "date hubs" [90] ).
Bioinformatics investigations of the binding partners of two mostly structured hubs, calmodulin and 14-3-3, suggest that the binding regions of their partners are very likely to be located in regions of disorder [91, 92] However, it has proven very difficult to globally test whether structured hubs bind to disordered partners. A difficulty with such studies is that the partners often contain both order and disorder, and the disordered regions typically comprise only small fractions of the partner sequences. Thus, without knowing the binding regions of the partners, it is difficult to estimate whether disorder is involved or not.
A search of PDB has revealed more than 2,500 short regions of one protein associated with a globular domain of a second protein. Further studies suggest that the short regions were very likely disordered before binding to their structured partners. Many of these short regions are related to each other, so the number reduces to several hundred families when they are grouped by sequence similarity. Most of these interactions are associated with signaling and regulation [93] . While we have not yet correlated these data with hub protein information, they show that disordered regions binding to structured partners is common, suggesting in turn that structured hub proteins may commonly bind to disordered partners.
Several years ago, without specific regard to networks, we considered possible roles of disorder in protein-protein interactions. We suggested that one disordered region could bind to many partners; we called this one-to-many signaling. We further suggested that flexibility would enable multiple disordered regions to bind to one site on one partner; we called this many to one signaling [84] . While papers back to 1936 suggest that flexibility could enable one protein to bind to many partners, we are unaware of a paper earlier than ours suggesting that flexibility would enable multiple disordered regions with different sequences to bind to single site on the partner protein.
To understand the structural principles in more detail, we recently studied carefully the structures of a one-to-many example (namely, the disordered regions in p53 binding to their many partners) and also the structures of a many-to-one example (namely many different disordered partners associating with the same binding site of 14-3-3).
For the one-to-many signaling example (using the structures currently in the PDB), a single disordered region of p53 is observed to form a helix when associating with one partner, a sheet with a second partner, an irregular structure with a third partner, and an irregular structure with a completely different trajectory with a fourth partner. The set of residues involved in these interactions exhibit a very high extent of overlap along the sequence [43] .
The solvent accessible surface area (ASA) can be calculated from the three dimensional structure of a protein analytically [94] or numerically [95] . The amount ASA that becomes inaccessible upon complex formation is likewise easy to estimate by existing methods [96] and is expressed as the change in the ASA or as the ∆ASA.
Plotting the ∆ASA for each amino acid versus its position in the sequence gives a binding profile. The binding profiles for the single region of p53 bound to four different partners are completely different. It is as if the same sequence is "read" by the different partners in entirely different ways [43] .
For a disordered region that binds to a partner, the binding profile comprises a highly localized set of amino acids. However, when the region of interaction is structured, the binding profile gives two (or more) localized sets separated by a considerable distance (or distances) along the sequence. The separated profile occurs because structured proteins bring together different regions of sequence to form the active site, which then leads to a binding profile that involves these separated regions of sequence. Interestingly, the DNA binding domain of p53 exhibits a complex but very distinctive binding profile when associating with DNA as compared to p53BP1 and p53BP2 [43] binding profiles. While both p53BP1 and p53BP2 profiles show similar localizations on the p53 sequence, their detailed structures are very different.
For a many-to-one signaling example (using structures currently in the PDB), five disordered sequences associated within a single binding groove in 14-3-3 were studied. As suggested previously [84] , the flexibility of the disordered regions enabled them to fit into a common binding site. Not only backbone flexibility, but also side-chain flexibility is implicated in the movements needed for the different sequences to be able to fit into the common binding site [43] .
What was not discussed in our earlier publication is the flexibility on the structured side of the complex (e.g. the flexibility in 14-3-3). In the 14-3-3 example, flexibility on the structured protein side of the complex also played a very important role in enabling the binding of many disordered segments to a single partner.
In 1958 Koshland proposed his now famous induced fit hypothesis. The original manuscript described a thoughtexperiment involving peptides of different sequences binding to a common site, thus requiring an "induced fit" to accommodate the different structures of the different sequences. While "induced fit" has been accepted and is described in current text books, the examples typically involve domain shifts. To our knowledge, our studies on the multiple peptides binding to 14-3-3 involve the first direct test of Koshland's original induced fit hypothesis. Further comparisons of these interactions confirm the Koshland's induced fit hypothesis with its original use of different sequences bound to a common partner and provide insight regarding the degree of structural change upon binding (manuscript in preparation).
IV. INTRINSIC DISORDER AND ALTERNATIVE SPLICING
Alternative splicing is a process whereby multiple, mature mRNAs are produced from a single precursor pre-mRNA by the inclusion and omission of different segments [97, 98] . The joined segments leading to the mRNA are called exons and the omitted segments are called introns [99] . Alternative splicing is only prevalent in multicellular eukaryotes [100] . Current estimates are that 40-60% of human genes yield proteins via alternative splicing [101] [102] [103] , and in many cases multiple proteins are produced from a single gene. These observations suggest that alternative splicing provides an important mechanism for enhancing the diversity of the proteome in multicellular eukaryotes [104] .
Alternative splicing impacts many protein functions such as ligand binding, enzymatic activity, and protein-protein interactions [105] [106] [107] . Not surprisingly, abnormal alternative splicing has been associated with human diseases, including myotonic dystrophy [108] , Axoospermia [109] , Alzheimer's [110] and cancer [111] .
Alternative splicing within a structured region of a protein would be expected to lead to significant problems with protein folding, thus leading simply to loss of function. In some cases, however, the alternatively spliced structured protein can maintain function.
Attempts have been made to predict the effects of alternative splicing on protein structure (and function) by homology modeling [112] and by a more sophisticated analysis that attempts to model the structural changes that are likely to result from the alternative splicing event [113] . This modeling could be attempted because the observed splicing alterations were of small size, were located on the protein surface, and were preferentially located in coil regions [113] . For these examples, the results suggested that the different splice variants folded into the same overall structure, with only slight, but perhaps functionally important, structural perturbations. So far we have been able to find only five alternatively spliced isozyme pairs with structures determined for both partners [114] [115] [116] [117] [118] . Consistent with the ideas presented in the modeling paper [113] , the protein isoforms did fold basically the same. These structures were not significantly perturbed because alternatively spliced segments were either short regions on the surface of the structure (in two cases) or disordered regions (in the remaining three cases). Of the two spliced surface segments the largest structural perturbation occurs where the RNA coding for a short helix was omitted in the shorter splice variant, which leads to a slight rearrangement when the adjacent secondary structure elements adjusted relative to each other due to the lack of the intervening, but short, helix. While this analysis would certainly benefit by additional structural data to test specific structural models, it suggests that alternatively spliced sites in ordered proteins are preferentially located in intrinsically disordered regions.
While the structural implications are interesting, it should be noted that only a small fraction of alternative splicing events clearly map to structured proteins. For example, while 40% to 60% of mammalian (human) genes are estimated to undergo alternative splicing, less than 20 individual proteins (out of over 6,000 structures of proteins from multicellular organisms in PDB 1 ) are known to have splice variants that map to the regions of structure (unpublished observations). What about all the other splicing events that (at least so far) don't map to any currently known structure?
For disorder-associated splicing, we hypothesized that the structural problems discussed above would be solved if the mRNA regions that vary for different isoforms were to code for regions of intrinsically disordered protein, as is observed for the three of five alternatively spliced enzyme pairs that we could find [114] [115] [116] [117] [118] . For regions of disorder, there could be multiple splice variants and the spliced regions could be long because structural perturbation is simply not an issue.
To test the possible association of alternative splicing with disorder, we assembled a set of human proteins that contained structurally characterized regions of structure and regions of disorder. We then searched for alternative splicing for each of these proteins. At the time of this study, we could find 46 human proteins with 75 alternatively spliced segments that met these criteria [44] . Of these 75 alternatively spliced regions of RNA, 57% coded for entirely disordered protein, 24% coded for both ordered and disordered protein (with the splice boundaries very often in, or very near to, the disordered regions), and just 19% coded for fully structured regions [44] . These 75 disorder-associated alternatively spliced regions are much larger than the number of regions known by direct experiment to be directly associated with regions of structure. Nevertheless, it would be very useful to enlarge the dataset.
To enlarge the dataset, we collected all of the proteins in SwissProt with identified alternatively spliced isoforms, giving 558 proteins with 1,266 regions that are absent on one isoform due to alternative splicing. We predicted order/disorder for these alternatively spliced proteins as well as for the 46 proteins of known structure. For both sets of data, we plotted the frequency of observation versus 0-20% predicted disorder, 20-40% predicted disorder, etc. For the 75 alternatively spliced regions of known structure, the predictions and observations gave excellent agreement. For the 1,266 regions that were present or absent in different isoforms due to alternative splicing, the frequencies of the various percentages of disorder closely matched the corresponding frequencies for the set of 75 with known structure. These data provide evidence that a large fraction of alternative splicing occurs in regions of RNA that code for disordered protein.
About 50% of mammalian proteins have predicted disordered regions of 30 residues or longer [74] . This estimate is in the ball park of 40% to 60% of proteins undergoing alternative splicing. Thus, intrinsic disorder is certainly common enough for 80% of alternative splicing events to occur in regions of disorder.
Above we discuss the roles of disorder in various protein functions and in protein-protein interaction networks. Alternative splicing could readily alter such functions and could readily alter protein-protein interaction networks. We suggest that the linkage between alternative splicing and signaling by disordered region provides a novel and plausible mechanism for understanding the origins of cell differentiation, which ultimately gave rise to multicellular organisms in nature [44] . New studies are needed to test these ideas.
V. INTRINSIC DISORDER AND DRUG DISCOVERY
Protein-protein interactions have long been regarded as a potential new source of drug targets. Systems biology approaches are mapping out the protein interactome, and a deeper understanding of these results is likely to indicate desirable drug targets [119] . However, attempts to develop drug molecules that block protein-protein interactions have generally not been successful [120, 121] . Indeed, our searches for drug molecules known to act by blocking protein-protein interactions have so far come up empty.
Upon this rather negative background, promising examples are creating a new optimism [122] [123] [124] . As described in these recent papers, several drug-like lead compounds act by blocking protein-protein interactions, and these are being actively investigated with the goal of developing new drugs.
We noticed that one interaction of interest, namely the interaction between p53 and Mdm2, has been the subject of numerous studies involving several molecules that could lead to a drug [125] [126] [127] . This particular example caught our attention because the same region of p53 involved in this interaction is known to be intrinsically disordered [128] . However, none of the papers discussing the promise of blocking this interaction even mention that the p53 side of the complex involves a disorder-to-order transition upon binding.
We used our bioinformatics and computational structural biology tools to investigate this interaction and discovered several features that explained why this region is so promising as a drug target. We then searched for analogous features (some of which are proprietary) over the entire human genome. The result was thousands of possible new drug targets that involve one disordered partner (and one structured partner) and that partition very nicely over the major diseases [45] . While much work needs to be done to turn these hypotheses into actual drug molecules, these discoveries certainly provide a new avenue for drug discovery that needs to be tested.
Here we point out that a protein-protein interaction involving one disordered partner and one structured partner is likely in many cases to be a good target for drug discovery. First, unlike the interactions between two globular proteins, the interaction surface involving one disordered partner is not flat. Typically the structured partner's surface has a groove, and the disordered region forms a helix with a hydrophobic face that nestles into the groove. We observe these features over and over in our MoRF dataset [93] and in the examples used to develop the MoRF predictor [67] . In the case of the p53-Mdm2 interaction, the Mdm2 forms the groove and the p53 binding site is predicted exactly as a MoRF.
Since one of the partners undergoes a disorder-to-order transition, some of the binding energy is spent to overcome the high entropy of the unfolded state. From the entropy point of view, such an interaction is likely to be weaker than an interaction between two structured proteins and thus will be easier to block with a small molecule competitor.
While protein disorder is not mentioned in any of the papers describing how a small molecule can block proteinprotein interactions, we have found that 4 of the 8 examples described in the recent reviews [122, 124] involve one structured partner and one disordered partner, with 3 of the 4 disordered segments becoming helix upon binding. Thus, the p53-Mdm2 complex is not the only member of this class currently known to be blocked by a small drug-like molecule. We fully expect many more examples to appear shortly, and for some of these examples to lead to useful drug molecules.
VI. SUMMARY COMMENTS
If we link the concepts here with those in Section V, a very exciting possibility is that these approaches will lead to tissuespecific drugs via tissue-specific alternative splicing in disordered regions.
If we link the concepts here with those in Section III, we can see how one drug molecule could block one protein-protein interaction (for one-to-many signaling interactions) but could block many interactions (for many-to-one signaling interactions).
Finally, if we link the concepts here with those in Sections II and III, we can possibly find drugs aimed at a wide variety of signaling and regulatory functions.
We started applying bioinformatics to disordered proteins about 12 years ago, with our first paper just slightly more than 10 years ago. In these few short years our understanding of the biological importance of these proteins has increased markedly. We hope that the next 10 years will see practical outcomes (such as promising leads for new drug molecules) from this work.
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